product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human MMP-7 Protein, CF
catalog :
907-MP-010
quantity :
10 ug
price :
388 USD
more info or order :
citations: 9
Reference
Mendes S, Amo Maestro L, Marino Puertas L, Diego I, Goulas T, Gomis Ruth F. Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases. Sci Rep. 2020;10:6317 pubmed publisher
Ye Y, Toczek J, Gona K, Kim H, Han J, Razavian M, et al. Novel Arginine-containing Macrocyclic MMP Inhibitors: Synthesis, 99mTc-labeling, and Evaluation. Sci Rep. 2018;8:11647 pubmed publisher
King S, Joshi H, Schjoldager K, Halim A, Madsen T, Dziegiel M, et al. Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells. Blood Adv. 2017;1:429-442 pubmed publisher
Willumsen N, Bager C, Leeming D, Bay Jensen A, Karsdal M. Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer. Neoplasia. 2017;19:271-278 pubmed publisher
Kristensen J, Karsdal M, Sand J, Willumsen N, Diefenbach C, Svensson B, et al. Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling. BMC Pulm Med. 2015;15:53 pubmed publisher
Djokic J, Fagotto Kaufmann C, Bartels R, Nelea V, Reinhardt D. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem. 2013;288:22821-35 pubmed publisher
Szarvas T, Singer B, Becker M, vom Dorp F, Jager T, Szendroi A, et al. Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer. BJU Int. 2011;107:1069-73 pubmed publisher
Hawinkels L, Verspaget H, Van den Berg M, Hanemaaijer R, Sier C. Determination of matrilysin activity in gastrointestinal neoplasia. Eur J Clin Invest. 2007;37:598-9 pubmed
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed
product information
brand :
R&D Systems
master code :
907-MP
SKU :
907-MP-010
product name :
Recombinant Human MMP-7 Protein, CF
unit size :
10 ug
description :
The Recombinant Human S100A7 Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human S100A7 Protein, CF has been validated for the following applications: Bioactivity.
target :
MMP-7
category :
Proteins and Enzymes
alt names :
EC 3.4.24, EC 3.4.24.23, matrilysin, Matrin, matrix metallopeptidase 7 (matrilysin, uterine), matrix metalloproteinase 7 (matrilysin, uterine), Matrix metalloproteinase-7, MMP7, MMP-7, MPSL1, PUMP1, PUMP-1, Pump-1 protease, uterine matrilysin, Uterine metalloproteinase
buffer :
Supplied as a 0.2 µm filtered solution in MES, NaCl and CaCl2.
conjugate :
Unconjugated
all available conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -70 °C as supplied. 3 months, -70 °C under sterile conditions after opening.
observed molecular weight :
28 kDa (major) 20 kDa (minor), reducing conditions
theoretical molecular weight :
28 kDa 20 kDa (Leu18-T198)
gene symbol :
MMP7
details of functionality :
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-PLGL-Dpa-AR-NH2 (Catalog # ES001 ). The specific activity is 600 pmol/min/µg, as measured under the described conditions.
endotoxin note :
<1.0 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
P09237
applications :
Enzyme Activity
source :
NS0-derived Recombinant Human MMP-7 Protein, CF
USD :
359
Jul-22 :
388 USD
sizes available :
10 ug
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.